Mihiri Weerasuria

Aussie ID doc with an interest in HIV Medicine ●
Twitter novice ●
Views are my own

[Mihiri Weerasuria @MWeerasuria]

@SamsungAU @Fernandizzzzle Join the flip side for a simpler life, reduced distractions, longer battery, and a touch of nostalgia - a refreshing break from the digital chaos! #SamsungGalaxy

[Mihiri Weerasuria @MWeerasuria]

What's a healthy amount of times to check the status of your manuscript submission??? Asking for a friend...😅😅

[Mihiri Weerasuria @MWeerasuria]

📣📣BREAKING NEWS at #IAS2023 the hon @ShannonFentiman announces QLD will remove co-payments for #HIV meds. Making it FREE regardless of Medicare status. Here's hoping Vic will be next.

[Mihiri Weerasuria @MWeerasuria]

@JillianLau1 with a knock out🥊 summary of the #HIVcure forum at #IAS2023!! So exciting to hear about all the new developments! 🎉 @HIVcureAU

[Mihiri Weerasuria @MWeerasuria]

Amazing plenary by @asiersc at #IAS2023 outlining what we know about PLHIV who can control/suppress #HIV w/o meds.

Particularly appreciated the inclusion of the perspectives of these PLHIV

Could these PLHIV "controllers" hold the key to #HIVcure? @HIVcureAU

[Mihiri Weerasuria @MWeerasuria]

So much respect and admiration for the speakers at #IAS2023

✔️ Executing mindblowing research 🤯
✔️ Summarising years (if not decades) of work into a 10-20min talk 🤯🤯
✔️ Presenting (often in a non-native language for them) in a way that I can understand 🤯🤯🤯

Thank you!

[HIV cure @HIVcureAU]

Yesterday at #IAS2023 Deliberate Discussions, @JillianLau1 chatted with Brent Clifton about some of the barriers of HIV trials and the disconnect between the reality of HIV Cure trials progress with what is being reported in the media. @iasociety @GileadSciences @brent_clifton

[Mihiri Weerasuria @MWeerasuria]

Fantastic presentation on the role of antibodies in #HIVprevention by
Dr Nyaradzo Mavis MGODI at #IAS2023.

BNAbs - treatment, prevention, (eventually #HIVcure (???)) is there anything they can't do?

[Mihiri Weerasuria @MWeerasuria]

Thank you @jmmolinaparis for a fantastic discussion on the pros and cons of #doxypep for #STIprevention at #IAS2023.

[Mihiri Weerasuria @MWeerasuria]

Fueling up for #IAS2023 Day 2 at @LuneCroissant in Brisbane. For any international delegates looking for a delicious pastry 🥐 and coffee ☕️definitely check it out!

[Mihiri Weerasuria @MWeerasuria]

Just heard results from @reprievetrial presented at #IAS2023 and published in @NEJM today. What does #idtwitter think?

Will you be putting all your PLHIV patients on statins?

[Mihiri Weerasuria @MWeerasuria]

We're told as med students that medicine is both an science and an art. It was beautiful and moving to see this in action @MetroArtsAU @ArtsHub. Beautiful pieces by Jaewon Kim, Jerome Kugan, Kairon Liu + many more in HIV Science as ART #ias2023

[Mihiri Weerasuria @MWeerasuria]

Prof Carol Camlin showcasing the power and effectiveness of community led approaches to link PLHIV into care at #IAS2023 👏🏽👏🏽

[Mihiri Weerasuria @MWeerasuria]

Wow. Thank you @katharine_bar for summarising the potential of antibody therapies in #HIVcure at #IAS2023. As an early career researcher, I was amazed by your clear and entertaining talk on such a complex concept. 👏🏽👏🏽👏🏽

[Mihiri Weerasuria @MWeerasuria]

Could we create a #HIV vaccine which would make the body produce antibodies to neutralise the virus (and stop it infecting cells)?

Dr Wilton Williams presents at #IAS2023

[World Health Organization (WHO) @WHO]

🆕WHO guidance on the role of #HIV viral suppression and undetectable levels of virus in both improving individual health and halting onward HIV transmission https://t.co/UbHxVwoAr8

[Mihiri Weerasuria @MWeerasuria]

@drdavidwjg Need more ID docs in the writers room clearly!

[Mihiri Weerasuria @MWeerasuria]

Wait...wasn't this the premise of #TheLastOfUs? 😨🧟‍♂️😨 Learning about the impact of #climatechange on fungal infections #IAS2023

[Mihiri Weerasuria @MWeerasuria]

"PLHIV who have an undectable VL have ZERO risk of transmitting the virus to their sexual partners."

Also exciting to see VL<1000 also negligible risk. Inspiring talk from Dr Lara Vojnov reporting on updated WHO guidelines at #IAS2023

[IAS - the International AIDS Society @iasociety]

.@QMUL and IAS GC member Chloe Orkin 🇬🇧 highlights the low recruitment of women and gender inequality of access to long-acting CAB-RPV for #HIV treatment in the current implementation studies, at #IAS2023. #PrEP